The National Drug Authority Strategic Plan 2020/2021-2024/2025 builds on the gains achieved in the previous period and also focuses on consolidating efficiency and effectiveness in drug regulation, as provided for within the mandate of the Drug Authority. This strategic plan has been aligned to the NDPIII programmes of Human Capital Development, Manufacturing, Agro-Industrialization, and Private Sector Development
0 Comments